Cleared Traditional

K222262 - Sunrise (FDA 510(k) Clearance)

Dec 2022
Decision
147d
Days
Class 2
Risk

K222262 is an FDA 510(k) clearance for the Sunrise. This device is classified as a Device For Sleep Apnea Testing Based On Mandibular Movement (Class II - Special Controls, product code QRS).

Submitted by Sunrise SA (Namur, BE). The FDA issued a Cleared decision on December 22, 2022, 147 days after receiving the submission on July 28, 2022.

This device falls under the Anesthesiology FDA review panel. Regulated under 21 CFR 868.2376. A Device For Sleep Apnea Testing Based On Mandibular Movement Is A Prescription Device Intended To Aid In Evaluation Of Sleep Apnea During Sleep In Patients Suspected Of Having Sleep Breathing Disorders By Analyzing Sensor Readings Of Mandibular Movement. The Device Is Not Intended As A Substitute For Full Polysomnography Nor Intended To Be Used As An Apnea Monitor..

Submission Details

510(k) Number K222262 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 28, 2022
Decision Date December 22, 2022
Days to Decision 147 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF

Device Classification

Product Code QRS - Device For Sleep Apnea Testing Based On Mandibular Movement
Device Class Class II - Special Controls
CFR Regulation 21 CFR 868.2376
Definition A Device For Sleep Apnea Testing Based On Mandibular Movement Is A Prescription Device Intended To Aid In Evaluation Of Sleep Apnea During Sleep In Patients Suspected Of Having Sleep Breathing Disorders By Analyzing Sensor Readings Of Mandibular Movement. The Device Is Not Intended As A Substitute For Full Polysomnography Nor Intended To Be Used As An Apnea Monitor.